Concepts (203)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name | Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Polymorphism, Single Nucleotide | 30 | 2013 | 16027 | 0.600 |
Why?
|
| PPAR gamma | 2 | 2010 | 487 | 0.540 |
Why?
|
| Obesity | 15 | 2013 | 13082 | 0.410 |
Why?
|
| Pyrophosphatases | 2 | 2007 | 142 | 0.330 |
Why?
|
| Phosphoric Diester Hydrolases | 2 | 2007 | 205 | 0.320 |
Why?
|
| Genetic Variation | 10 | 2013 | 6606 | 0.260 |
Why?
|
| Body Mass Index | 10 | 2013 | 13050 | 0.260 |
Why?
|
| Adiposity | 3 | 2010 | 1895 | 0.250 |
Why?
|
| Gene Frequency | 9 | 2013 | 3615 | 0.220 |
Why?
|
| Phenytoin | 1 | 2003 | 190 | 0.210 |
Why?
|
| Genetic Predisposition to Disease | 15 | 2013 | 18047 | 0.210 |
Why?
|
| Genome-Wide Association Study | 12 | 2013 | 12775 | 0.210 |
Why?
|
| Breast Feeding | 1 | 2010 | 1364 | 0.200 |
Why?
|
| Intracellular Signaling Peptides and Proteins | 3 | 2009 | 2889 | 0.180 |
Why?
|
| CADASIL | 1 | 2021 | 83 | 0.180 |
Why?
|
| Genetics, Population | 5 | 2010 | 942 | 0.180 |
Why?
|
| Abnormalities, Drug-Induced | 1 | 2003 | 340 | 0.180 |
Why?
|
| Polymorphism, Genetic | 2 | 2010 | 4250 | 0.180 |
Why?
|
| Skinfold Thickness | 2 | 2010 | 164 | 0.180 |
Why?
|
| Amino Acid Substitution | 3 | 2010 | 1743 | 0.170 |
Why?
|
| Linkage Disequilibrium | 8 | 2013 | 1998 | 0.170 |
Why?
|
| Proteins | 3 | 2010 | 6006 | 0.160 |
Why?
|
| Genotype | 14 | 2013 | 13038 | 0.160 |
Why?
|
| Interleukin-10 | 2 | 2005 | 1184 | 0.160 |
Why?
|
| Asthma | 7 | 2013 | 6281 | 0.160 |
Why?
|
| Abnormalities, Multiple | 2 | 2021 | 1424 | 0.160 |
Why?
|
| Chromosome Mapping | 7 | 2010 | 4622 | 0.160 |
Why?
|
| Waist Circumference | 3 | 2010 | 935 | 0.150 |
Why?
|
| Craniosynostoses | 1 | 2021 | 415 | 0.140 |
Why?
|
| Quantitative Trait Loci | 4 | 2012 | 2127 | 0.140 |
Why?
|
| Genetic Linkage | 3 | 2008 | 2342 | 0.130 |
Why?
|
| Genetic Loci | 5 | 2013 | 2630 | 0.130 |
Why?
|
| Membrane Proteins | 4 | 2013 | 7885 | 0.120 |
Why?
|
| Ischemia | 1 | 2003 | 1900 | 0.120 |
Why?
|
| Haplotypes | 6 | 2011 | 2724 | 0.120 |
Why?
|
| Phenotype | 5 | 2011 | 16716 | 0.120 |
Why?
|
| Body Weight | 3 | 2010 | 4630 | 0.110 |
Why?
|
| Anticonvulsants | 1 | 2003 | 1923 | 0.110 |
Why?
|
| Chromosomes, Human, Pair 10 | 1 | 2013 | 277 | 0.100 |
Why?
|
| Waist-Hip Ratio | 2 | 2010 | 520 | 0.100 |
Why?
|
| Diabetes Mellitus | 2 | 2010 | 5890 | 0.100 |
Why?
|
| Diet | 1 | 2010 | 8097 | 0.100 |
Why?
|
| Aging | 1 | 2010 | 8764 | 0.090 |
Why?
|
| Cohort Studies | 15 | 2012 | 41791 | 0.090 |
Why?
|
| Genome, Human | 6 | 2010 | 4450 | 0.090 |
Why?
|
| Gene Pool | 1 | 2010 | 36 | 0.090 |
Why?
|
| Greece | 1 | 2010 | 340 | 0.090 |
Why?
|
| Lysophospholipase | 1 | 2009 | 66 | 0.080 |
Why?
|
| Transcription Factor AP-2 | 1 | 2009 | 79 | 0.080 |
Why?
|
| Sexual Maturation | 1 | 2010 | 261 | 0.080 |
Why?
|
| Body Fat Distribution | 1 | 2009 | 246 | 0.070 |
Why?
|
| Cyclins | 1 | 2010 | 606 | 0.070 |
Why?
|
| Receptor, Melanocortin, Type 4 | 1 | 2008 | 131 | 0.070 |
Why?
|
| Receptors, Neuropeptide Y | 1 | 2007 | 47 | 0.070 |
Why?
|
| Oxidoreductases | 1 | 2009 | 412 | 0.070 |
Why?
|
| HLA Antigens | 1 | 2012 | 1337 | 0.070 |
Why?
|
| Sequence Tagged Sites | 1 | 2006 | 96 | 0.070 |
Why?
|
| Poland | 1 | 2006 | 197 | 0.070 |
Why?
|
| Neuropeptide Y | 1 | 2007 | 194 | 0.060 |
Why?
|
| Child | 9 | 2011 | 80894 | 0.060 |
Why?
|
| Models, Genetic | 5 | 2010 | 3442 | 0.060 |
Why?
|
| Isoenzymes | 1 | 2010 | 1684 | 0.060 |
Why?
|
| Introns | 2 | 2007 | 968 | 0.060 |
Why?
|
| Oligonucleotide Array Sequence Analysis | 2 | 2011 | 3794 | 0.060 |
Why?
|
| Female | 25 | 2021 | 397050 | 0.060 |
Why?
|
| Chi-Square Distribution | 1 | 2010 | 3438 | 0.060 |
Why?
|
| Diabetes Mellitus, Type 2 | 5 | 2010 | 12239 | 0.060 |
Why?
|
| Homozygote | 1 | 2009 | 1779 | 0.060 |
Why?
|
| Body Height | 1 | 2010 | 1568 | 0.060 |
Why?
|
| Male | 22 | 2013 | 364870 | 0.050 |
Why?
|
| Humans | 38 | 2021 | 768298 | 0.050 |
Why?
|
| Alleles | 6 | 2010 | 6892 | 0.050 |
Why?
|
| Sequence Analysis, DNA | 2 | 2011 | 4774 | 0.050 |
Why?
|
| Siblings | 1 | 2006 | 829 | 0.050 |
Why?
|
| Dietary Fats | 1 | 2010 | 2003 | 0.050 |
Why?
|
| Phylogeny | 1 | 2010 | 2842 | 0.050 |
Why?
|
| Respiratory Hypersensitivity | 1 | 2004 | 272 | 0.050 |
Why?
|
| Heart Arrest, Induced | 1 | 2003 | 361 | 0.050 |
Why?
|
| Receptors, Immunologic | 1 | 2008 | 1416 | 0.050 |
Why?
|
| 3' Untranslated Regions | 1 | 2004 | 515 | 0.050 |
Why?
|
| Chromosomes, Human, Pair 1 | 1 | 2004 | 640 | 0.050 |
Why?
|
| Meningocele | 1 | 2021 | 50 | 0.050 |
Why?
|
| Central Nervous System | 1 | 2008 | 1346 | 0.050 |
Why?
|
| DNA Copy Number Variations | 1 | 2010 | 2046 | 0.050 |
Why?
|
| Jamaica | 2 | 2010 | 54 | 0.040 |
Why?
|
| Linear Models | 1 | 2010 | 5878 | 0.040 |
Why?
|
| Weight Gain | 1 | 2010 | 2358 | 0.040 |
Why?
|
| Motor Activity | 1 | 2010 | 2720 | 0.040 |
Why?
|
| Genetic Markers | 4 | 2010 | 2604 | 0.040 |
Why?
|
| Lipids | 1 | 2010 | 3344 | 0.040 |
Why?
|
| Triglycerides | 1 | 2007 | 2465 | 0.040 |
Why?
|
| Quantitative Trait, Heritable | 3 | 2008 | 540 | 0.040 |
Why?
|
| Meta-Analysis as Topic | 3 | 2008 | 1364 | 0.040 |
Why?
|
| Computer Simulation | 6 | 2011 | 6277 | 0.040 |
Why?
|
| Forced Expiratory Volume | 1 | 2004 | 1820 | 0.040 |
Why?
|
| Cardiopulmonary Bypass | 1 | 2003 | 1097 | 0.040 |
Why?
|
| Feeding Behavior | 1 | 2010 | 3203 | 0.040 |
Why?
|
| Insulin Resistance | 2 | 2009 | 3981 | 0.040 |
Why?
|
| Adult | 15 | 2012 | 223622 | 0.040 |
Why?
|
| Pedigree | 1 | 2005 | 4545 | 0.040 |
Why?
|
| Statistics, Nonparametric | 1 | 2003 | 2862 | 0.030 |
Why?
|
| Principal Component Analysis | 2 | 2010 | 948 | 0.030 |
Why?
|
| Research Design | 2 | 2009 | 6209 | 0.030 |
Why?
|
| Risk | 1 | 2009 | 9635 | 0.030 |
Why?
|
| Maternal Exposure | 1 | 2003 | 1079 | 0.030 |
Why?
|
| Cytokines | 1 | 2011 | 7443 | 0.030 |
Why?
|
| Case-Control Studies | 6 | 2013 | 22292 | 0.030 |
Why?
|
| Nerve Tissue Proteins | 1 | 2008 | 4414 | 0.030 |
Why?
|
| Middle Aged | 14 | 2012 | 223463 | 0.030 |
Why?
|
| Genetic Testing | 2 | 2008 | 3587 | 0.030 |
Why?
|
| Sex Factors | 1 | 2009 | 10656 | 0.030 |
Why?
|
| Anthropometry | 2 | 2010 | 1343 | 0.030 |
Why?
|
| Gestational Age | 1 | 2003 | 3615 | 0.030 |
Why?
|
| Genes, Recessive | 2 | 2007 | 625 | 0.030 |
Why?
|
| Receptors, Interleukin-18 | 1 | 2013 | 25 | 0.030 |
Why?
|
| Acid Anhydride Hydrolases | 1 | 2013 | 67 | 0.030 |
Why?
|
| Aged | 11 | 2011 | 171544 | 0.030 |
Why?
|
| Data Interpretation, Statistical | 1 | 2003 | 2708 | 0.030 |
Why?
|
| Promoter Regions, Genetic | 1 | 2004 | 5800 | 0.030 |
Why?
|
| Reproducibility of Results | 2 | 2010 | 20224 | 0.020 |
Why?
|
| Receptors, Interleukin-1 | 1 | 2013 | 260 | 0.020 |
Why?
|
| DNA Repair Enzymes | 1 | 2013 | 346 | 0.020 |
Why?
|
| Interleukin-13 | 1 | 2013 | 391 | 0.020 |
Why?
|
| Hypertension | 1 | 2011 | 8615 | 0.020 |
Why?
|
| Myocardium | 1 | 2003 | 4788 | 0.020 |
Why?
|
| Child, Preschool | 2 | 2010 | 42654 | 0.020 |
Why?
|
| Illinois | 1 | 2010 | 120 | 0.020 |
Why?
|
| Pregnancy | 3 | 2010 | 30198 | 0.020 |
Why?
|
| Pregnancy Complications | 1 | 2003 | 2971 | 0.020 |
Why?
|
| Population Groups | 1 | 2010 | 208 | 0.020 |
Why?
|
| Methionine Sulfoxide Reductases | 1 | 2009 | 77 | 0.020 |
Why?
|
| Risk Assessment | 1 | 2010 | 24316 | 0.020 |
Why?
|
| Time Factors | 1 | 2010 | 40267 | 0.020 |
Why?
|
| Systole | 1 | 2011 | 937 | 0.020 |
Why?
|
| Diastole | 1 | 2011 | 784 | 0.020 |
Why?
|
| Muscle, Skeletal | 1 | 2003 | 4981 | 0.020 |
Why?
|
| Epilepsy | 1 | 2003 | 3326 | 0.020 |
Why?
|
| Menarche | 1 | 2011 | 538 | 0.020 |
Why?
|
| Cation Transport Proteins | 1 | 2010 | 326 | 0.020 |
Why?
|
| Chromosomes, Human, Pair 18 | 1 | 2008 | 247 | 0.020 |
Why?
|
| Quality Control | 1 | 2010 | 833 | 0.020 |
Why?
|
| Nigeria | 1 | 2010 | 779 | 0.020 |
Why?
|
| Adolescent | 6 | 2011 | 89182 | 0.020 |
Why?
|
| Risk Factors | 2 | 2012 | 74954 | 0.020 |
Why?
|
| Human Genome Project | 1 | 2006 | 202 | 0.020 |
Why?
|
| Insulin-Like Growth Factor Binding Proteins | 1 | 2007 | 208 | 0.020 |
Why?
|
| Smoking | 1 | 2003 | 9109 | 0.020 |
Why?
|
| Selection, Genetic | 1 | 2010 | 877 | 0.020 |
Why?
|
| Gene Expression Regulation | 1 | 2003 | 11914 | 0.020 |
Why?
|
| Chromosomes, Human, Pair 9 | 1 | 2007 | 534 | 0.020 |
Why?
|
| Models, Statistical | 2 | 2010 | 5099 | 0.020 |
Why?
|
| Gene Dosage | 1 | 2008 | 1221 | 0.010 |
Why?
|
| Infant | 2 | 2021 | 36512 | 0.010 |
Why?
|
| Genes, jun | 1 | 2003 | 69 | 0.010 |
Why?
|
| Genetic Association Studies | 1 | 2013 | 2741 | 0.010 |
Why?
|
| Heterozygote | 1 | 2010 | 2792 | 0.010 |
Why?
|
| Genes, fos | 1 | 2003 | 176 | 0.010 |
Why?
|
| Urban Population | 1 | 2011 | 2045 | 0.010 |
Why?
|
| Infant, Newborn | 1 | 2003 | 26410 | 0.010 |
Why?
|
| Culture Techniques | 1 | 2003 | 530 | 0.010 |
Why?
|
| Proto-Oncogenes | 1 | 2003 | 322 | 0.010 |
Why?
|
| Blood Glucose | 2 | 2007 | 6430 | 0.010 |
Why?
|
| Bayes Theorem | 1 | 2010 | 2353 | 0.010 |
Why?
|
| Sampling Studies | 1 | 2003 | 616 | 0.010 |
Why?
|
| Blotting, Northern | 1 | 2003 | 1553 | 0.010 |
Why?
|
| Birth Weight | 1 | 2010 | 2114 | 0.010 |
Why?
|
| Neoplasm Proteins | 1 | 2013 | 3609 | 0.010 |
Why?
|
| Insulin-Secreting Cells | 1 | 2007 | 899 | 0.010 |
Why?
|
| Dendritic Cells | 1 | 2011 | 2749 | 0.010 |
Why?
|
| Interleukin-1 | 1 | 2003 | 1251 | 0.010 |
Why?
|
| Intercellular Adhesion Molecule-1 | 1 | 2003 | 1133 | 0.010 |
Why?
|
| Reference Values | 1 | 2007 | 4941 | 0.010 |
Why?
|
| In Situ Hybridization | 1 | 2003 | 1905 | 0.010 |
Why?
|
| Europe | 1 | 2006 | 3439 | 0.010 |
Why?
|
| Young Adult | 3 | 2010 | 60048 | 0.010 |
Why?
|
| Postoperative Period | 1 | 2003 | 1830 | 0.010 |
Why?
|
| United States | 1 | 2006 | 73144 | 0.010 |
Why?
|
| Glucose | 1 | 2010 | 4354 | 0.010 |
Why?
|
| Multivariate Analysis | 1 | 2010 | 12092 | 0.010 |
Why?
|
| Mutation | 1 | 2021 | 30230 | 0.010 |
Why?
|
| Cross-Sectional Studies | 2 | 2008 | 26373 | 0.010 |
Why?
|
| Environment | 1 | 2003 | 1125 | 0.010 |
Why?
|
| Adaptor Proteins, Signal Transducing | 1 | 2007 | 2911 | 0.010 |
Why?
|
| Reverse Transcriptase Polymerase Chain Reaction | 1 | 2003 | 4584 | 0.010 |
Why?
|
| Sex Characteristics | 1 | 2007 | 2661 | 0.010 |
Why?
|
| Heart Diseases | 1 | 2009 | 2819 | 0.010 |
Why?
|
| DNA-Binding Proteins | 1 | 2013 | 9618 | 0.010 |
Why?
|
| Blood Pressure | 1 | 2011 | 8541 | 0.010 |
Why?
|
| Up-Regulation | 1 | 2003 | 4137 | 0.010 |
Why?
|
| Longitudinal Studies | 1 | 2010 | 14783 | 0.010 |
Why?
|
| Anti-Inflammatory Agents | 1 | 2003 | 1812 | 0.010 |
Why?
|
| Base Sequence | 1 | 2003 | 12421 | 0.010 |
Why?
|
| Tumor Necrosis Factor-alpha | 1 | 2003 | 4357 | 0.010 |
Why?
|
| Age Factors | 1 | 2008 | 18472 | 0.010 |
Why?
|
| Software | 1 | 2005 | 4452 | 0.010 |
Why?
|
| Randomized Controlled Trials as Topic | 1 | 2008 | 10377 | 0.010 |
Why?
|
| Molecular Sequence Data | 1 | 2003 | 17626 | 0.010 |
Why?
|
| RNA, Messenger | 1 | 2003 | 12801 | 0.000 |
Why?
|
| Sensitivity and Specificity | 1 | 2003 | 14736 | 0.000 |
Why?
|
| Prostatic Neoplasms | 1 | 2006 | 11220 | 0.000 |
Why?
|
| Aged, 80 and over | 1 | 2008 | 59683 | 0.000 |
Why?
|
| Algorithms | 1 | 2003 | 14154 | 0.000 |
Why?
|
| Breast Neoplasms | 1 | 2006 | 21163 | 0.000 |
Why?
|
Concepts
(203)
Derived automatically from this person's publications.
Explore
_
Co-Authors
(45)
People in Profiles who have published with this person.
Explore
_
Similar People
(60)
People who share similar concepts with this person.
Explore
_
Same Department
People in same department with this person.
Explore
_
Physical Neighbors
People whose addresses are nearby this person.
_